These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22831465)

  • 1. Long-acting somatostatin analogues decrease blood transfusion requirements in patients with refractory gastrointestinal bleeding associated with angiodysplasia.
    Bon C; Aparicio T; Vincent M; Mavros M; Bejou B; Raynaud JJ; Zampeli E; Airinei G; Sautereau D; Benamouzig R; Michopoulos S
    Aliment Pharmacol Ther; 2012 Sep; 36(6):587-93. PubMed ID: 22831465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and predictors of response to somatostatin analogues in patients with gastrointestinal angiodysplasias: a systematic review and individual patient data meta-analysis.
    Goltstein LCMJ; Grooteman KV; Rocco A; Holleran G; Frago S; Salgueiro PS; Aparicio T; Scaglione G; Chetcuti Zammit S; Prados-Manzano R; Benamouzig R; Nardone G; McNamara D; Benallaoua M; Michopoulos S; Sidhu R; Kievit W; Drenth JPH; van Geenen EJM
    Lancet Gastroenterol Hepatol; 2021 Nov; 6(11):922-932. PubMed ID: 34508668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Somatostatin analogues in the treatment of bleeding GI-angiodysplasias].
    Boesby L; Christensen NJ; Kristensen LO
    Ugeskr Laeger; 2008 Mar; 170(11):958. PubMed ID: 18397628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long acting release-octreotide as "rescue" therapy to control angiodysplasia bleeding: A retrospective study of 98 cases.
    Nardone G; Compare D; Scarpignato C; Rocco A
    Dig Liver Dis; 2014 Aug; 46(8):688-94. PubMed ID: 24893688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term efficacy of octreotide in the prevention of recurrent bleeding from gastrointestinal angiodysplasia.
    Junquera F; Saperas E; Videla S; Feu F; Vilaseca J; Armengol JR; Bordas JM; Piqué JM; Malagelada JR
    Am J Gastroenterol; 2007 Feb; 102(2):254-60. PubMed ID: 17311647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Octreotide in the treatment of angiodysplasia in patients with advanced chronic renal failure].
    Rivera M; Lucero J; Guerrero A; Márquez JL; Montes R; Suñer M; Ruiz A; Valdivia MA; Mateos J
    Nefrologia; 2005; 25(3):332-5. PubMed ID: 16053016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results with lanreotide in patients with recurrent gastrointestinal angiodysplasias bleeding or obscure gastrointestinal bleeding. Benefits in efficacy and procedures consumption.
    Frago S; Alcedo J; Martín Pena-Galo E; Lázaro M; Ollero L; de la Llama N
    Scand J Gastroenterol; 2018 Dec; 53(12):1496-1502. PubMed ID: 30621520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-acting somatostatin analogues provide significant beneficial effect in patients with refractory small bowel angiodysplasia: Results from a proof of concept open label mono-centre trial.
    Holleran G; Hall B; Breslin N; McNamara D
    United European Gastroenterol J; 2016 Feb; 4(1):70-6. PubMed ID: 26966525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-acting octreotide as rescue therapy in chronic bleeding from gastrointestinal angiodysplasia.
    Scaglione G; Pietrini L; Russo F; Franco MR; Sorrentini I
    Aliment Pharmacol Ther; 2007 Sep; 26(6):935-42. PubMed ID: 17767478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macroscopic appearance of intestinal angiodysplasias under antiangiogenic treatment with thalidomide.
    Bauditz J; Lochs H; Voderholzer W
    Endoscopy; 2006 Oct; 38(10):1036-9. PubMed ID: 17058171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of argon plasma ablation therapy for bleeding in 100 consecutive patients with colonic angiodysplasia.
    Olmos JA; Marcolongo M; Pogorelsky V; Herrera L; Tobal F; Dávolos JR
    Dis Colon Rectum; 2006 Oct; 49(10):1507-16. PubMed ID: 17024322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of push enteroscopy on transfusion requirements and quality of life in patients with unexplained gastrointestinal bleeding.
    Vakil N; Huilgol V; Khan I
    Am J Gastroenterol; 1997 Mar; 92(3):425-8. PubMed ID: 9068462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin analogues in the treatment of recurrent bleeding from gastrointestinal vascular malformations: an overview and systematic review of prospective observational studies.
    Brown C; Subramanian V; Wilcox CM; Peter S
    Dig Dis Sci; 2010 Aug; 55(8):2129-34. PubMed ID: 20393879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bleeding gastrointestinal angiodysplasias: our experience and a review of the literature].
    Lonardo A; Greco M; Grisendi A
    Ann Ital Med Int; 2004; 19(2):122-7. PubMed ID: 15317273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of somatostatin in the management of upper gastrointestinal bleeding].
    Herszényi L
    Orv Hetil; 2002 May; 143(19 Suppl):1092-9. PubMed ID: 12063868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of gastrointestinal angiodysplastic lesions (GIADs): a systematic review and meta-analysis.
    Jackson CS; Gerson LB
    Am J Gastroenterol; 2014 Apr; 109(4):474-83; quiz 484. PubMed ID: 24642577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standard of Care Versus Octreotide in Angiodysplasia-Related Bleeding (the OCEAN Study): A Multicenter Randomized Controlled Trial.
    Goltstein LCMJ; Grooteman KV; Bernts LHP; Scheffer RCH; Laheij RJF; Gilissen LPL; Schrauwen RWM; Talstra NC; Zuur AT; Braat H; Hadithi M; Brouwer JT; Nagengast WB; Oort FA; Tenthof van Noorden J; Kievit W; van Geenen EJM; Drenth JPH
    Gastroenterology; 2024 Apr; 166(4):690-703. PubMed ID: 38158089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A woman in her 60s with multifactorial anaemia].
    Frigstad SO; Jønsson V; Moum B
    Tidsskr Nor Laegeforen; 2012 Apr; 132(8):965-8. PubMed ID: 22562330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thalidomide for the treatment of recurrent gastrointestinal blood loss due to intestinal angiodysplasias].
    de Koning DB; Drenth JP; Friederich P; Nagengast FM
    Ned Tijdschr Geneeskd; 2006 Sep; 150(36):1994-7. PubMed ID: 17002190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic failure with thalidomide in patients with recurrent intestinal bleeding due to angiodysplasias.
    Izquierdo Navarro Mdel C; Hernando Verdugo M; Cardaba Garcia E; Sanchez Sanchez MT
    Farm Hosp; 2016 May; 40(3):230-2. PubMed ID: 27145393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.